In APP/PS1 transgenic mice AD model, intranasal incorporation of human NSCs that differentiate into cholinergic neurons decrease β-amyloid accumulation by increasing neprilysin expression along with enzymes that can degrade β-amyloid. Here, APP is linked to Alzheimer disease.